Announcements

    Drinks

      THURSDAY, 25/01/2018 - Scope Ratings AG
      Download PDF

      Sanofi ratings unaffected by Bioverativ acquisition

      Scope believes that the recently announced USD 11.6 bn acquisition of US-based biotech company Bioverativ is not a challenge for Sanofi’s credit rating.

      While the transaction, which is still pending regulatory approval, is fully funded by a combination of cash and additional debt, its likely negative impact on Sanofi’s financial risk profile is of insignificant relevance in the context of the ratings. This is not to say credit metrics will not deteriorate in 2018 compared to the previous year, but Scope believes that the likely deterioration will not be strong enough to justify a negative rating action.

      Scope had stated in its last outlook statement that the rating reflects Sanofi being able to maintain the following Scope-adjusted credit metrics: funds from operations to debt of 60%, and free operating cash flow to debt of at least 40%. The agency does not believe that the acquisition of Bioverativ is likely to endanger these thresholds meaningfully and can thus maintain the ratings.

      Related news

      Show all
      Scope upgrades short-term debt rating on Axpo Holding and Axpo International to S-1+ from S-1

      21/10/2025 Rating announcement

      Scope upgrades short-term debt rating on Axpo Holding and ...

      Scope has completed a monitoring review for Otthon Centrum

      20/10/2025 Monitoring note

      Scope has completed a monitoring review for Otthon Centrum

      Scope affirms A-/Stable issuer rating of Tensio AS

      17/10/2025 Rating announcement

      Scope affirms A-/Stable issuer rating of Tensio AS

      Scope affirms GOPD’s issuer rating at B-, maintains the Negative Outlook

      17/10/2025 Rating announcement

      Scope affirms GOPD’s issuer rating at B-, maintains the ...

      Scope affirms the issuer rating of Hungarian real estate developer SunDell at B-/Stable

      17/10/2025 Rating announcement

      Scope affirms the issuer rating of Hungarian real estate ...

      Scope affirms and withdraws the BB-/Stable issuer rating on Global Refuse Holding

      16/10/2025 Rating announcement

      Scope affirms and withdraws the BB-/Stable issuer rating on ...